STLN insider trading
Starling Oncology, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Buys · last 90 days
1 · $78k
Most recent buy
2026-08-17
Recent insider filings
| Filed | Insider | Type | Shares | Price | Value |
|---|
| 2026-08-24 | Hively Brad Director | Sold | 298,853 | $6.51 | $1.9M |
| 2026-08-17 | Chernett Jorey 10% owner | Bought | 12,000 | $6.54 | $78k |
Most active insider buyers
| Insider | Role | Buys | Total bought |
|---|
| Chernett Jorey | 10% owner | 1 | $78k |
See STLN on the chart
Every insider buy and sell for STLN plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.
Open the browserFree sampleData from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.